BioMelbourne Network
Progressing BioIndustry

News and Opinions

Previous1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9

2015

January

Circadian announces: US Patent Granted for Soluble VEGFR-3 Traps

28 January 2015.  Circadian Technologies Limited, through its wholly-owned subsidiary Vegenics Pty Ltd, is pleased to announce the grant of US Patent Number 8,940,695 on 27 January 2015. This US patent protects compositions containing soluble VEGFR-3 fusion proteins, such as OPT-302. Circadian is developing OPT-302 for the treatment of wet AMD (age-related macular degeneration) through its wh... read more…

Peter Lewis of Hydrix appointed a Member of the Order of Australia (AM) for services to ‘International Trade, Biotechnology and ICT’.

27 January 2015.  Peter Lewis, a high profile figure in the Australian biomedical devices industry was was appointed a Member of the Order of Australia (AM) on the 2015 Australia Day Honours list for his services to ‘International Trade, Biotechnology and ICT’. Mr Lewis is an accomplished senior executive with over 25 years’ experience leading growth strategies for technology based companies t... read more…

Sienna Readies for Next Phase of Growth - Chief Executive Officer Dr Kerry Hegarty to Step Down

22 January 2015.  Sienna Cancer Diagnostics Ltd, a Melbourne-based biotechnology company, focused on developing novel in vitro diagnostics tests for cancer, has today announced that Managing Director and Chief Executive Officer Dr Kerry Hegarty will step down from her position, after ten years in the role.Her resignation comes on the heels of recent transformational events for Sienna Cancer Dia... read more…

Murdoch Childrens-led mobile health APP, PEERSTM, a top 20 finalist in the OzAPP awards

20 January 2015.  Murdoch Childrens Research Institute has been named as a top 20 finalist in the 2014 – 15 OzAPP Awards for the development of a tablet-based app called PEERSTM. The OzAPP awards bring together the best mobile, web and cloud based app concepts in the Asia Pacific region. PEERSTM (Paediatric evaluation of emotions relationships and socialization) will be the first clinically-va... read more…

Invion Announces Positive Interim Data from its Phase II Clinical Trial of Oral INV102 (Nadolol) in Smoking Cessation

19 January 2015.  Invion Limited (ASX: IVX) is pleased to announce positive interim data from its phase II double-blind placebo-controlled randomised clinical trial in patients with chronic cough or established COPD who are trying to quit smoking but have failed multiple times previously. The interim data is generated from an assessment of sputum (phlegm) samples collected from patients upon r... read more…

Phosphagenics Appoints Dr Ross Murdoch as Chief Executive Officer

14 January 2015.  After an extensive global search, Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY) is pleased to announce the appointment of Dr Ross Murdoch as CEO. Dr Murdoch has more than 25 years of experience leading and managing the strategic, scientific and operational aspects of product research, development and commercialisation across the healthcare, ... read more…

Academia-industry Alliance Towards Autoimmune Disease

12 January 2015.   Monash University announced today that it has signed a research collaboration agreement with Janssen-Cilag Pty Ltd. (Janssen), one of the Janssen Pharmaceutical companies of Johnson & Johnson. The collaboration, facilitated by Johnson & Johnson Innovation, Asia Pacific, will focus on ground-breaking research at Monash University to develop potential new medicines to treat au... read more…

Melbourne Cancer Biotech Sienna Strikes First Big Deal with US Firm

8 January 2015.   Melbourne biotechnology start-up Sienna Cancer Diagnostics, which is backed by ex-Macquarie boss Allan Moss, has signed its first deal with an American pathology company paving the way for a potential float this year. The unlisted company, which was a beneficiary of the now defunct Commercialisation Australia grant program, will seek to raise $10 million. Chief executive Ke... read more…

2014

December

Premier Daniel Andrews finalises ministers' portfolios

4 December 2014.   The BioMelbourne Network welcomes the new Victorian Government Ministry, as announced today by Premier Daniel Andrew. We look forward to working Ministers in supporting innovative businesses and entrepreneurship in the biotechnology and medical technology sector. In particular, we look forward to collaborating with Adem Somyurek the Minister For Small Business, Innovation an... read more…
November

Innovation Key to Jobs and Growth Under Labor

28 November 2014.  While the Napthine Government cut funding to science, technology, engineering and innovation by 60 per cent, Innovation and job creation will be key to Victorian jobs and growth under an Andrews Labor Government.Labor will establish the Premier’s Jobs and Investment Panel, using the unique insight of the private sector on how to invest $500 million to create high-skill, high-... read more…